Lithium: Clinical Considerations in Internal Medicine

American Journal of Medicine

Volumn 119, Issue 6, 2006, Pages 478-481

  Freeman, Marlene P ^a   Freeman, Scott A ^b  

^a Women's Mental Health Program   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Depression; Lithium; Mania; Mood stabilizer

Indexed keywords

AMILORIDE; ANTICONVULSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LITHIUM; LOOP DIURETIC AGENT; MOOD STABILIZER; NONSTEROID ANTIINFLAMMATORY AGENT; OSMOTIC DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; THYROXINE; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ADOLESCENCE; ARTICLE; ATRIOVENTRICULAR BLOCK; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BRAIN DISEASE; CARDIOTOXICITY; CARDIOVASCULAR MALFORMATION; CHILDHOOD; CLINICAL TRIAL; COGNITIVE DEFECT; COORDINATION DISORDER; DELIRIUM; DIABETES INSIPIDUS; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG INTOXICATION; DRUG OVERDOSE; EBSTEIN ANOMALY; EEG ABNORMALITY; ELECTROCONVULSIVE THERAPY; GERIATRIC PATIENT; HEART DISEASE; HUMAN; HYPOTHYROIDISM; INTERNAL MEDICINE; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LABORATORY TEST; LACTATION; MAJOR DEPRESSION; MANIA; MOOD DISORDER; NEPHROTOXICITY; NEURAL TUBE DEFECT; NEUROTOXICITY; PATIENT MONITORING; POLYPHARMACY; POLYURIA; PRACTICE GUIDELINE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOPHARMACOTHERAPY; RISK FACTOR; SIDE EFFECT; SINUS BRADYCARDIA; SINUS NODE DYSFUNCTION; SUICIDAL BEHAVIOR; T WAVE; TERATOGENICITY; TOXICOLOGY; TREMOR; WEIGHT GAIN;

EID: 33646913835     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.11.003     Document Type: Note

References (70)

1. th edn. (1994), American Psychiatric Association, Washington, DC
2. Dunner D.L. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord 5 (2003) 456-463
3. Cade J.F. Lithium salts in the treatment of psychotic excitement. Med J Aust 36 (1949) 349-352
4. Jefferson J.W., and Greist J.H. Primer of Lithium Therapy (1977), Williams and Wilkins Company, Baltimore, MD xii
5. Baldessarini R.J., and Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry 57 (2000) 187-190
6. Kilts C.D. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. J Clin Psychiatry 61 (2000) 41-46
7. Ward M.E., Musa M.N., and Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol 34 (1994) 280-285
8. Baldessarini R.J., and Tarazi F.I. Drugs and the treatment of psychiatric disorders. psychosis and mania. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th edn. (2001), McGraw Hill, New York, NY 485-520
9. Finley P., Warner M., and Peabody C. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 29 (1995) 172-191
10. Keck Jr. P.E., and McElroy S.L. Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. J Clin Psychiatry 63 suppl 4 (2002) 3-11
11. Birch N.J., Greenfield A.A., and Hullin R.P. Pharmacodynamic aspects of long-term prophylactic lithium. Int Pharmacopsychiatry 15 (1980) 91-98
12. Schou M., Juel-Nielson N., and Stromgren E. The treatment of manic psychoses by administration of lithium salts. J Neurol Neurosurg Psychiatry 17 (1954) 250-260
13. Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 109 (1963) 56-65
14. Goodwin F.K., Murphy D.L., and Bunny W.F. Lithium carbonate treatment in depression and mania. a longitudinal double-blind study. Arch Gen Psychiatry 21 (1969) 486-496
15. Stokes P.E., Shamoian C.A., Stoll P.M., and Patton M.J. Efficacy of lithium as acute treatment of manic depressive illness. Lancet 1 (1971) 1319-1325
16. Bowden C.L., Brugger A.M., Swann A.C., et al. Efficacy of divalproex vs. lithium and placebo in the treatment of acute mania. JAMA 271 (1994) 918-924
17. Segal J., Berk M., and Brook S. Risperidone compared with both lithium and haloperidol in mania. a double-blind randomized controlled trial. Clin Neuropharmacol 21 (1998) 176-180
18. Takahashi R., Sakuma A., Itoh K., and Kurihara M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 32 (1975) 1310-1318
19. Reeves R.R., Struve F.A., and Patrick G. Does EEG predict response to valproate versus lithium in patients with mania?. Ann Clin Psychiatry 13 (2001) 69-73
20. Swann A.C., Bowden C.L., Morris D., et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54 (1997) 37-42
21. Dunner D.L., and Fieve R.R. Clinical factors in lithium prophylaxis failure. Arch Gen Psychiatry 30 (1974) 229-233
22. Compton M.T., and Nemeroff C.B. The treatment of bipolar depression. J Clin Psychiatry 61 Suppl (2002) 57-67
23. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159 Suppl (2002) 1-50
24. Goodwin F.K., and Jamison K.R. Manic Depressive Illness (1990), Oxford University Press, New York, NY
25. Schou M. The effect of prophylactic lithium treatment on mortality and suicidal behavior. a review for clinicians. J Affect Disord 50 (1998) 253-259
26. Tondo L., Jamison K.R., and Baldessarini R.J. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci 836 (1997) 339-351
27. Baldessarini R.J., Tondo L., and Viguera A. Discontinuing lithium maintenance treatment in bipolar disorders. risks and implications. Bipolar Disord 1 (1999) 17-24
28. Tondo L., Baldessarini R.J., Hennen J., and Floris G. Lithium maintenance treatment of depression and mania in bipolar I and II disorders. Am J Psychiatry 155 (1998) 638-645
29. Rosenthal N.E., Rosenthal L.N., Stallone F., et al. Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. J Affect Disord 1 (1979) 237-245
30. Maj M. Clinical prediction of response to lithium prophylaxis in bipolar patients. the importance of the previous pattern of course of the illness. Clin Neuropharmacol 13 Suppl 1 (1990) S66-S0
31. Kulhara P., Basu D., Mattoo S.K., Sharan P., and Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder. long-term outcome and its psychosocial correlates. J Affect Disord 54 (1999) 87-96
32. Austin M.P.V., Souza F.G.M., and Goodwin G.M. Lithium augmentation in antidepressant-resistant patients. a quantitative analysis. Br J Psychiatry 159 (1991) 510-514
33. Heit S., and Nemeroff C.B. Lithium augmentation of antidepressants in treatment-refractory depression. J Clin Psychiatry 59 Suppl 6 (1998) 28-33
34. Schopf J., Baumann P., Lemarchand T., et al. Treatment of endogenous depressions resistant to tricyclic antidepressants of related drugs by lithium addition. results of a placebo-controlled double-blind study. Pharmacopsychiatry 22 (1989) 183-187
35. Stein G., and Bernadt B. Lithium augmentation therapy in tricyclic-resistant depression. Br J Psychiatry 162 (1993) 634-640
36. Heninger G.R., Charney D.S., and Sternberg D.E. Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 40 (1983) 1335-1342
37. Zusky P.M., Biederman J., Rosenbaum J.F., et al. Adjunct low dose lithium carbonate in lithium-resistant depression. a placebo-controlled study. J Clin Psychopharmacol 8 (1988) 120-124
38. Kantor D., McNevin S., Leichner P., et al. The benefit of lithium carbonate adjunct in refractory depression. Am J Psychiatry 31 (1986) 416-418
39. Ryan N.D., Bhatara V.S., and Perel J.M. Mood stabilizers in children and adolescents. J Am Acad Child Adolesc Psychiatry 38 (1999) 529-536
40. Kowatch R.A., Suppes T., Carmody T.J., et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39 (2000) 713-720
41. Geller B., Cooper T.B., Zimerman B., et al. Lithium for prepubertal depressed children with family history predictors of future bipolarity. a double-blind, placebo-controlled study. J Affect Disord 51 (1998) 165-175
42. Campbell M., Silva R.R., Kafantaris V., et al. Predictors of side effects associated with lithium administration in children. Psychopharmacol Bull 27 (1991) 373-380
43. Chen G., Huang L.D., Jiang Y.M., and Manji H.K. The mood stabilizing agent valproate inhibits the activity of glycogen synthase kinase 3. J Neurochem 72 (1999) 1327-1330
44. Conney J., and Kaston B. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population. influence of drug-related morbidity on total cost of treatment. Am J Manag Care 5 (1999) 197-204
45. Hardy B.G., Shulman K.I., Mackenzie S.E., Kutcher S.P., and Silverberg J.D. Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol 7 (1987) 153-158
46. Stoudemire A., Moran M.G., and Fogel B.S. Psychotropic drug use in the medically ill. Psychosomatics 21 (1990) 377-391
47. Cohen L.S., Friedman J.M., Jefferson J.W., et al. A reevaluation of risk of in utero exposure to lithium. JAMA 271 (1994) 146-150
48. Weinstein M.R., and Goldfield M.D. Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 132 (1975) 529-531
49. Cohen L.S., and Rosenbaum J.F. Psychotropic use during pregnancy. weighing the risks. J Clin Psychiatry 59 (1998) 18-28
50. Viguera A.C., and Cohen L.S. The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull 34 (1998) 339-346
51. Chaudron L.H., and Jefferson J.W. Mood stabilizers during breastfeeding. a review. J Clin Psychiatry 61 (2000) 79-90
52. Gitlin M.J., Cochran S.D., and Jamison K.R. Maintenance lithium treatment. side effects and compliance. J Clin Psychiatry 51 (1990) 126-127
53. West A.P., and Meltzer H.Y. Paradoxical lithium neurotoxicity. a report of 5 cases and a hypothesis about risk for neurotoxicity. Am J Psychiatry 136 (1979) 963-966
54. Gelenberg A.J., and Jefferson J.W. Lithium tremor. J Clin Psychiatry 56 (1995) 283-287
55. Bocchetta A., Mossa P., Velluzzi F., Mariotti S., Del Zompo M., and Loviselli A. Ten-year follow-up of thyroid function in lithium patients. J Clin Psychopharmacol 21 (2001) 594-598
56. Kirov G. Thyroid disorders in lithium-treated patients. J Affect Disord 50 (1998) 33-40
57. Lombardi G., Panza N., Biondi B., et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis. a longitudinal study. J Endocrinol Invest 16 (1993) 259-263
58. Kusalic M., and Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci 24 (1999) 227-233
59. Gitlin M. Lithium and the kidney. an updated review. Drug Saf 20 (1999) 231-243
60. Bendz H., and Aurell M. Drug-induced diabetes insipidus. incidence, prevention and management. Drug Saf 21 (1999) 449-456
61. Fenves A.Z., Emmett M., and White M.G. Lithium intoxication associated with acute renal failure. South Med J 77 (1984) 1472-1474
62. Steckler T.L. Lithium- and carbamazepine-associated sinus node dysfunction. nine-year experience in a psychiatric hospital. J Clin Psychopharmacol 14 (1994) 336-339
63. Martin C.A., and Piascik M.T. First degree A-V block in patients on lithium carbonate. Can J Psychiatry 30 (1985) 114-116
64. Mitchell P., Withers K., Jacobs G., and Hickie I. Combining lithium with sodium valproate for bipolar disorder. Aust N Z J Psychiatry 28 (1984) 141-143
65. Tilkian A.G., Schroeder J.S., Kao J.J., and Hultgren H.N. The cardiovascular effects of lithium in man. A review of the literature. Am J Med 61 (1976) 665-670
66. Roose S.P., Nurnberger J.I., Dunner D.L., et al. Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry 136 (1979) 804-806
67. Freeman M.P., and Stoll A.L. Mood stabilizers in combination. a review of safety and efficacy. Am J Psychiatry 155 (1998) 12-21
68. Johnson A.G., Seideman P., and Day R.O. Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance. Drug Saf 8 (1993) 99-127
69. Finley P., Warner M., and Peabody C. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 29 (1995) 172-191
70. DasGupta K., Jefferson J.W., Kobak K.A., and Greist J.H. The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry 53 (1992) 398-400